Notice of Fiscal Policies in Effect for FY 2020

February 11, 2020

This Notice provides guidance about the NIH Fiscal Operations for FY 2020 and implements The Further Consolidated Appropriations Act, 2020 (Public Law 116-94), signed into law on December 20, 2019. With the passage of the Act, NIH received a 5.9 percent increase over FY 2019 Enacted, for a total of $41.64 billion in program level funding including $492,000,000 authorized under the 21st Century Cures Act and specific increases for Alzheimer’s disease, All of Us, the BRAIN Initiative, and the Childhood Cancer Data Initiative. The mandatory funding for Type 1 Diabetes provided in PL 116-94 through May 22, 2020, is $96.58 million.

Continue reading →